SteelPeak Wealth LLC Sells 262,950 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

SteelPeak Wealth LLC decreased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 90.5% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 27,596 shares of the pharmacy operator's stock after selling 262,950 shares during the quarter. SteelPeak Wealth LLC's holdings in Walgreens Boots Alliance were worth $247,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of WBA. Pinnacle Associates Ltd. bought a new stake in Walgreens Boots Alliance in the 3rd quarter worth approximately $111,000. Integrated Advisors Network LLC purchased a new position in shares of Walgreens Boots Alliance in the third quarter valued at $165,000. abrdn plc increased its position in Walgreens Boots Alliance by 7.3% in the third quarter. abrdn plc now owns 351,288 shares of the pharmacy operator's stock worth $3,181,000 after purchasing an additional 23,751 shares during the last quarter. Semanteon Capital Management LP purchased a new position in shares of Walgreens Boots Alliance in the 3rd quarter worth $278,000. Finally, Frank Rimerman Advisors LLC bought a new stake in shares of Walgreens Boots Alliance in the 3rd quarter worth about $170,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Jefferies Financial Group lowered their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a "hold" rating for the company in a report on Wednesday, October 23rd. Evercore ISI increased their price target on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an "in-line" rating in a report on Wednesday, October 16th. Barclays lifted their price objective on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an "underweight" rating in a research note on Wednesday, October 16th. Morgan Stanley dropped their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating for the company in a research note on Friday, October 11th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an "overweight" rating on the stock in a research report on Friday, August 30th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, Walgreens Boots Alliance has a consensus rating of "Hold" and an average price target of $12.88.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA remained flat at $9.46 during midday trading on Friday. The company had a trading volume of 12,190,103 shares, compared to its average volume of 25,700,582. The company's 50 day simple moving average is $9.20 and its 200-day simple moving average is $12.47. The stock has a market capitalization of $8.18 billion, a P/E ratio of -0.95, a price-to-earnings-growth ratio of 1.24 and a beta of 0.68. Walgreens Boots Alliance, Inc. has a 52 week low of $8.22 and a 52 week high of $27.05. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.36 by $0.03. The business had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business's revenue was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.67 EPS. On average, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be paid a dividend of $0.25 per share. The ex-dividend date is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.57%. Walgreens Boots Alliance's dividend payout ratio is presently -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.